CNX-024

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCNX-024
Drug Alias NameCNX-024
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionExtracellular matrix protein modulators
TargetsExtracellular matrix protein
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesConnexios Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesConnexios Life Sciences
Active IndicationsN/A
Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A